5-(1-(5-(methylsulfonyl)pyridin-2-yl)-3-(trifluoromethyl)-1H-pyrazol-5-yl)-2-(thiazol-2-yl)benzonitrile

ID: ALA206207

Chembl Id: CHEMBL206207

PubChem CID: 18768821

Max Phase: Preclinical

Molecular Formula: C20H12F3N5O2S2

Molecular Weight: 475.48

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CS(=O)(=O)c1ccc(-n2nc(C(F)(F)F)cc2-c2ccc(-c3nccs3)c(C#N)c2)nc1

Standard InChI:  InChI=1S/C20H12F3N5O2S2/c1-32(29,30)14-3-5-18(26-11-14)28-16(9-17(27-28)20(21,22)23)12-2-4-15(13(8-12)10-24)19-25-6-7-31-19/h2-9,11H,1H3

Standard InChI Key:  QHQAKSMOAUBKBQ-UHFFFAOYSA-N

Associated Targets(non-human)

COX-2 Cyclooxygenase-2 (160 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGS1 Cyclooxygenase-1 (107 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 475.48Molecular Weight (Monoisotopic): 475.0385AlogP: 4.35#Rotatable Bonds: 4
Polar Surface Area: 101.53Molecular Species: NEUTRALHBA: 8HBD:
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 2.36CX LogP: 3.65CX LogD: 3.65
Aromatic Rings: 4Heavy Atoms: 32QED Weighted: 0.43Np Likeness Score: -2.00

References

1. Cheng H, Lundy DeMello KM, Li J, Sakya SM, Ando K, Kawamura K, Kato T, Rafka RJ, Jaynes BH, Ziegler CB, Stevens R, Lund LA, Mann DW, Kilroy C, Haven ML, Nimz EL, Dutra JK, Li C, Minich ML, Kolosko NL, Petras C, Silvia AM, Seibel SB..  (2006)  Synthesis and SAR of heteroaryl-phenyl-substituted pyrazole derivatives as highly selective and potent canine COX-2 inhibitors.,  16  (8): [PMID:16464588] [10.1016/j.bmcl.2006.01.059]

Source